Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

108

CIRM-FUNDED CLINICAL TRIALS

Disease AreasInvestigatorOrganizationPhaseTrial StatusTarget EnrollmentDetail
Brain Cancer Dr. Christine E. Brown City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 82
Lung Cancer Dr. Steven M. Dubinett MD University of California, Los Angeles Phase 1 Active, not recruiting 24
Melanoma Robert Dillman Caladrius Biosciences Phase 3 Closed 4
Melanoma
Skin cancer
Dr. Antoni Ribas MD/PhD University of California, Los Angeles Phase 1 Closed 5
Sarcoma Theodore Scott Nowicki University of California, Los Angeles Phase 1 Closed 5
Blood Cancer
Solid Tumors
Dr. Irving L Weissman MD Stanford University Phase 1 Completed 88
Solid Tumors Dr. Dennis J Slamon University of California, Los Angeles Phase 1 Completed 46
Colon Cancer Mark Chao Forty Seven Inc. Phase 1/2 Completed 78
Brain Cancer Dr Jana Portnow City of Hope, Beckman Research Institute Phase 1 Launching N/A
Colon Cancer Ivan King Tachyon Therapeutics, Inc Phase 1 Launching N/A
Solid Tumors Pei Wang Eureka Therapeutics, Inc. Phase 1/2 Launching N/A
Brain Cancer Dr. Reena Parada Thomas Stanford University Phase 1 Launching N/A
Melanoma Anusha Kalbasi Stanford University Phase 1 Launching N/A
Brain Cancer Dr. Hideho Okada University of California, San Francisco Phase 1 Launching N/A
Brain Cancer Noriyuki Kasahara University of California, San Francisco Phase 1 Launching N/A
Solid Tumors Dr. John Le Gall Allogene Therapeutics Phase 1 Launching N/A
Brain Cancer
Breast Cancer
Dr Saul J Priceman City of Hope, Beckman Research Institute Phase 1 Recruiting 39
Brain Cancer Dr. Leo D Wang City of Hope, Beckman Research Institute Phase 1 Recruiting 18
Brain Cancer Crystal Mackall Stanford University Phase 1 Recruiting 54
Solid Tumors Dr. Pamela Reilly Contag BioEclipse Therapeutics INC. Phase 1 Recruiting 60
Brain Cancer Anthony J. Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 234